Gut Microbiota Influences on Drug Efficacy, Metabolism and Adverse Reactions

The field of human health is increasingly recognizing the significant influence of gut microbiota on various physiological and pharmacological processes. Recent research has shed light on the intricate interplay between gut microorganisms and drug metabolism, unveiling their potential to alter drug efficacy and contribute to adverse effects. However, despite the growing body of work in this area, many aspects of these interactions remain poorly understood. Questions persist regarding how specific microorganisms may enhance or diminish drug action, as well as how alterations in the microbiome might be leveraged therapeutically. Furthermore, understanding the dynamics between gut microbiota and pharmaceutical compounds presents complex challenges, requiring a more nuanced investigation of their multifaceted interactions.

This Research Topic aims to explore the critical role played by gut microbiota in shaping drug efficacy and mediating side effects, with a specific focus on the implications for human health. By examining existing questions and potential mechanisms of influence, the goal is to enhance our understanding of how the microbiome can affect drug response. We aim to address key areas of interest, including the microbiome's capacity to metabolize pharmaceuticals, its impact on drug absorption and distribution, and its role in mediating immune responses to treatments. Through this exploration, the research seeks to identify strategies for optimizing pharmacotherapy and personalized medicine.

To gather further insights in gut microbiome and drug interactions, we welcome articles addressing, but not limited to, the following themes:

- Contributions of gut microbiota to drug metabolism and detoxification processes.
- Interactions between specific bacterial strains and pharmaceutical compounds.
- Impact of gut microbiome alterations on therapeutic efficacy in chronic inflammatory diseases.
- Role of intestinal microbiota in modulating drug-induced toxicities and side effects.
- Personalized approaches to pharmacotherapy based on individual microbiome profiles.

This Research Topic will focus on elucidating detailed knowledge regarding the interactions within gut microbiota and their implications for human health and disease, particularly in relation to pharmacology and therapeutic outcomes.

Topic Editor, Prof. Toshifumi Ohkusa, receives financial support from Morinaga Milk Industry Co., Ltd since 2017. The other Topic Editors report no competing interests related to this Research Topic.